SEVE MANUEL: Open Payments
NPI 1235540881 · GRANDVIEW, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 12 payments from 8 companies in 2025. Trend: 2023 $203 · 2024 $292 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $117 |
| Neurocrine BioSciences, Inc. | 4 | $104 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Novo Nordisk Inc | 1 | $23 |
| Incyte Corporation | 1 | $19 |
| Exact Sciences Corporation | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
Products named: AIRSUPRA, INGREZZA, CAPLYTA, Wegovy, NIKTIMVO, The Cologuard Plus Collection Kit, ROTATEQ, Dexcom G6 Transmitter.
Industry payments across WA — which companies pay providers there.
